EUVIMEDEUVIMED entdecken
Crossref

ABRefine: An Accurate Antibody Structure Refinement Method by Equivariant Graph Transformer with Rigid Body Constraint

Jinxian Wang iD, Ziqiao Zhang, Xiaoyang Jing, Shuangjia Zheng, Jihong Guan, Shuigeng Zhou

Journal of Medicinal Chemistry · 11.06.2026 · 69 (11) · 12925-12940

DOI: 10.1021/acs.jmedchem.5c03435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 19.05.2026. Verfasst von Jinxian Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Computer Science and Artificial Intelligence, Fudan University, 2005 Songhu RD, 200438 Shanghai, China. Hauptthemen laut MEDLINE: Antibodies, Single-Domain Antibodies. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate antibody structural modeling is essential for therapeutic antibody development. However, even advanced artificial intelligence models such as AlphaFold2/3 struggle to precisely predict antibody structures due to the high flexibility of the complementarity-determining regions. Structure refinement methods can therefore play a critical role in improving the quality of predicted antibody conformations. In this paper, we present ABRefine, an end-to-end antibody structure refinement framework based on an equivariant graph transformer with rigid-body constraints. ABRefine directly predicts atomic coordinate shifts from initial structures while enforcing physically meaningful rigid-body consistency, enabling rapid and accurate refinement without conformational sampling. To our knowledge, ABRefine is also the first dedicated refinement method for nanobodies. Comprehensive evaluations on multiple antibody and nanobody benchmarks show that ABRefine outperforms existing refinement methods in both accuracy and efficiency, and notably enhances the structural quality of AlphaFold3 predictions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntibodiesSingle-Domain AntibodiesModels, MolecularProtein ConformationAlgorithms

Substanzen

AntibodiesSingle-Domain Antibodies

Autor:innen und Institutionen

  • College of Computer Science and Artificial Intelligence, Fudan University, 2005 Songhu RD, 200438 Shanghai, China.
  • Lingang Laboratory, 2380 Hechuan RD, 201100 Shanghai, China.
  • Changchun GeneScience Pharmaceuticals Co., Ltd., 130000 Changchun, China.
  • Global Institute of Future Technology, Shanghai Jiao Tong University, 800 Dongchuan, 200240 Shanghai, China.
  • School of Computer Science and Technology, Tongji University, 4800 Cao'an RD, 200618 Shanghai, China.

ORCID-Profile: Jinxian Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, J., Zhang, Z., Jing, X., Zheng, S., Guan, J., & Zhou, S. (2026). ABRefine: An Accurate Antibody Structure Refinement Method by Equivariant Graph Transformer with Rigid Body Constraint. Journal of Medicinal Chemistry, 69(11), 12925-12940. https://doi.org/10.1021/acs.jmedchem.5c03435

Vancouver

Wang J, Zhang Z, Jing X, Zheng S, Guan J, Zhou S. ABRefine: An Accurate Antibody Structure Refinement Method by Equivariant Graph Transformer with Rigid Body Constraint. Journal of Medicinal Chemistry. 2026;69(11):12925-12940. doi:10.1021/acs.jmedchem.5c03435

BibTeX
@article{Wang2026,
  author = {Wang, Jinxian and Zhang, Ziqiao and Jing, Xiaoyang and Zheng, Shuangjia and Guan, Jihong and Zhou, Shuigeng},
  title = {ABRefine: An Accurate Antibody Structure Refinement Method by Equivariant Graph Transformer with Rigid Body Constraint},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {11},
  pages = {12925--12940},
  doi = {10.1021/acs.jmedchem.5c03435}
}
Kostenlos starten →